Glooko announced today that it secured $100 million in a financing round and appointed Mike Alvarez as its new CEO.

Clearside Biomedical today announced that the ODYSSEY study of its drug-device combination achieved its primary and secondary ...

BD (NYSE:BDX) announced today that it entered into a collaboration with ten23 health to develop a new way to track ...

Trinity Biotech today announced that it completed the first pre-pivotal clinical trial in Europe for its next-generation CGM ...

Qnovia announced that the FDA cleared its investigational new drug (IND) application for the RespiRx smoking cessation ...

Medinol today announced the successful first-in-human implantation of its ChampioNIR drug-eluting peripheral stent.

Injection delivery system developer ApiJect announced that it promoted Molly Weaver to the position of chief operating ...

Eyenovia (Nasdaq:EYEN) announced that it began manufacturing batches of its Mydcombi product for its next-generation delivery ...

Ascensia Diabetes Care announced today that it launched the Eversense 365 CGM system from Senseonics (NYSE:SENS) ...

MannKind announced top-level 30-week results from its Phase 4 INHALE-3 study comparing inhaled insulin to traditional ...

Stevanato Group announced today that it expanded the capacity of its Vertiva on-body device for subcutaneous large-volume ...

The National Institutes of Health (NIH) launched a nationwide consortium to address the rise in youth diagnosed with type 2 ...